Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study (Q43980170)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study
scientific article

    Statements

    Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study (English)
    Rene Westhovens
    Joel M Kremer
    Larry W Moreland
    Anthony S Russell
    Tracy Li
    Richard Aranda
    Jean-Claude Becker
    Keqin Qi
    27 February 2009
    736-742

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit